BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 21658857)

  • 1. Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion.
    Shimizu S; Osaka Y; Shinohara N; Sazawa A; Nishioka K; Suzuki R; Onimaru R; Shirato H
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e393-9. PubMed ID: 21658857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers.
    Nishioka K; Shimizu S; Shinohara N; Ito YM; Abe T; Maruyama S; Katoh N; Kinoshita R; Hashimoto T; Miyamoto N; Onimaru R; Shirato H
    Radiat Oncol; 2017 Mar; 12(1):44. PubMed ID: 28249609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
    Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
    Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the three degrees-of-freedom fiducial marker-based setup compared to soft tissue-based setup in hypofractionated intensity-modulated radiotherapy for prostate cancer.
    Tanabe S; Utsunomiya S; Abe E; Sato H; Ohta A; Sakai H; Yamada T; Kaidu M; Aoyama H
    J Appl Clin Med Phys; 2019 Jun; 20(6):53-59. PubMed ID: 31054217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate and patient intrafraction motion: impact on treatment time-dependent planning margins for patients with endorectal balloon.
    Steiner E; Georg D; Goldner G; Stock M
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):755-61. PubMed ID: 23582854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapy to correct for inter- and intrafractional rotations of the prostate.
    Deutschmann H; Kametriser G; Steininger P; Scherer P; Schöller H; Gaisberger C; Mooslechner M; Mitterlechner B; Weichenberger H; Fastner G; Wurstbauer K; Jeschke S; Forstner R; Sedlmayer F
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1624-32. PubMed ID: 22209149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Day-to-day reproducibility of prostate intrafraction motion assessed by multiple kV and MV imaging of implanted markers during treatment.
    Mutanga TF; de Boer HC; Rajan V; Dirkx ML; Incrocci L; Heijmen BJ
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):400-7. PubMed ID: 22019244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.
    Böckelmann F; Putz F; Kallis K; Lettmaier S; Fietkau R; Bert C
    Strahlenther Onkol; 2020 Jul; 196(7):647-656. PubMed ID: 32157345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion.
    Tanyi JA; He T; Summers PA; Mburu RG; Kato CM; Rhodes SM; Hung AY; Fuss M
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1579-85. PubMed ID: 20472357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential failure risk of the cone-beam computed tomography-based planning target volume margin definition for prostate image-guided radiotherapy based on a prospective single-institutional hybrid analysis.
    Hirose K; Sato M; Hatayama Y; Kawaguchi H; Komai F; Sohma M; Obara H; Suzuki M; Tanaka M; Fujioka I; Ichise K; Takai Y; Aoki M
    Radiat Oncol; 2018 Jun; 13(1):106. PubMed ID: 29880006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superiority of a soft tissue-based setup using cone-beam computed tomography over a bony structure-based setup in intensity-modulated radiotherapy for prostate cancer.
    Sato H; Abe E; Utsunomiya S; Kaidu M; Yamana N; Tanaka K; Ohta A; Obinata M; Liu J; Kawaguchi G; Maruyama K; Ayukawa F; Aoyama H
    J Appl Clin Med Phys; 2015 Sep; 16(5):239–245. PubMed ID: 26699304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilizing the TrueBeam Advanced Imaging Package to monitor intrafraction motion with periodic kV imaging and automatic marker detection during VMAT prostate treatments.
    Korpics MC; Rokni M; Degnan M; Aydogan B; Liauw SL; Redler G
    J Appl Clin Med Phys; 2020 Mar; 21(3):184-191. PubMed ID: 31981305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Position verification for the prostate: effect on rectal wall dose.
    Haverkort MA; van de Kamer JB; Pieters BR; van Tienhoven G; Assendelft E; Lensing AL; van Herk M; de Reijke TM; Stoker J; Koning CC
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):462-8. PubMed ID: 20646865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kilovoltage intrafraction monitoring during normofractionated prostate cancer radiotherapy.
    Chasseray M; Dissaux G; Lucia F; Boussion N; Goasduff G; Pradier O; Bourbonne V; Schick U
    Cancer Radiother; 2020 Apr; 24(2):99-105. PubMed ID: 32201058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implanted dosimeters identify radiation overdoses during IMRT for prostate cancer.
    Den RB; Nowak K; Buzurovic I; Cao J; Harrison AS; Lawrence YR; Dicker AP; Showalter TN
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e371-6. PubMed ID: 22633553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-Time 3D Image Guidance Using a Standard LINAC: Measured Motion, Accuracy, and Precision of the First Prospective Clinical Trial of Kilovoltage Intrafraction Monitoring-Guided Gating for Prostate Cancer Radiation Therapy.
    Keall PJ; Ng JA; Juneja P; O'Brien RT; Huang CY; Colvill E; Caillet V; Simpson E; Poulsen PR; Kneebone A; Eade T; Booth JT
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1015-21. PubMed ID: 27026307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter- and intrafraction uncertainty in prostate bed image-guided radiotherapy.
    Huang K; Palma DA; Scott D; McGregor D; Gaede S; Yartsev S; Bauman G; Louie AV; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):402-7. PubMed ID: 22381905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Margin evaluation in the presence of deformation, rotation, and translation in prostate and entire seminal vesicle irradiation with daily marker-based setup corrections.
    Mutanga TF; de Boer HC; van der Wielen GJ; Hoogeman MS; Incrocci L; Heijmen BJ
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1160-7. PubMed ID: 21035957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive inter- and intrafractional motion control in ultrahypofractionated radiation therapy of prostate cancer using RayPilot HypoCath™-a substitute for gold fiducial-based IGRT?
    Berchtold J; Winkler C; Karner J; Groher M; Gaisberger C; Sedlmayer F; Wolf F
    Strahlenther Onkol; 2024 Mar; 200(3):195-201. PubMed ID: 37626226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative assessment of prostate positioning guided by three-dimensional ultrasound and cone beam CT.
    Li M; Ballhausen H; Hegemann NS; Ganswindt U; Manapov F; Tritschler S; Roosen A; Gratzke C; Reiner M; Belka C
    Radiat Oncol; 2015 Apr; 10():82. PubMed ID: 25890013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.